Halaven 0.5mg Injection is a chemotherapy drug that contains the active substance eribulin, which belongs to the class of antineoplastic agents. Halaven 0.5mg Injection is used in adults for advanced breast cancer or liposarcoma (a type of cancer originating from fat tissue) when other treatments have stopped working.

It is not recommended to take Halaven 0.5mg Injection if you are allergic to Eribulin or any of its other ingredients. Consult your doctor if you believe this applies to you. It is not recommended for children and adolescents younger than 18 years since the effects of Halaven 0.5mg Injection in this population are unknown. Before starting the treatment, you should inform your physician if you have fever, infections, liver, or heart problems. Before starting the treatment, give a detailed account of your medical history and medications.